TrialGynecologic oncology2014

A phase II trial of brivanib in recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study.

Matthew A Powell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.